Johnson & Johnson receives subpoenas over supervision of some subsidiaries |
|
|
|
Published
:
Mon, 12 Mar 2007 14:27
|
LONDON (AFX) - Johnson & Johnson said it has received separate subpoenas from the US Attorney's Office in Philadelphia, Boston and San Francisco, related to investigations of the sales and marketing of the drugs Risperdal by Janssen, Topamax by Ortho-McNeil and Natrecor by Scios -- each subsidiaries of Johnson & Johnson.The subpoenas reportedly request information regarding Johnson & Johnson's corporate supervision and oversight of these three subsidiaries, including their sales and marketing of these drugs.Johnson & Johnson said it will cooperate in responding to the requests.newsdesk@afxnews.comrwCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Johnson & Johnson units under review 